Novo Nordisk, Pfizer metabolic news

The companies settled a lawsuit in which NVO alleged PFE's Exubera inhaled insulin infringed NVO's patents covering inhalable insulin. NVO filed the lawsuit in the U.S. District Court for the Southern...